Tympanogen Company

This project seeks to improve the process of antibiotic release from a novel patch that can treat military combat wounds and reduce the occurrence and severity of sepsis, or systemic inflammation. This novel patch contains a hydrogel with inherent antimicrobial properties that can promote healing of a wound while acting as a scaffold for regenerating tissue. Reduced fluid motion in microgravity will allow for more precise studies of this hydrogel behavior and its controlled release from the patch.
Industry: Risk Mitigation
Headquarters: USA
Founded Date: 2014
Total Funding: n/a

Visit Website
Register and Claim Ownership